- ICH GCP
- 미국 임상 시험 레지스트리
- 임상시험 NCT04908007
COvid Pandemic Institutional maNaGement (COPING)
Institutional Management and Professional Experience During the Pandemic COVID-19 by Health Care Institutions in the Auvergne-Rhône-Alpes Region: Assessment and Lessons Learned
Covid-19 has increased organizational tensions within health services (lack of resources, difficulties in recruiting healthcare professionals , elderly and polypathological patients, etc.) and tested the reliability of health facilities. This project aims to draw lessons so that hospitals can transform themselves while improving their reliability to face future crises and other exceptional situations.
Research hypothesis:
Crisis management arrangements lack sensitivity to uncertainty, which manifests itself in lower quality of care and efficiency losses for the entire institution.
The virtuous practices implemented during the crisis spontaneously incorporated principles of the highly reliable organization.
The integration of principles from complexity theory into the management of institutions promotes high reliability organization.
Sustaining these virtuous practices in order to anticipate and cope with crises requires the activation of two interconnected levers: a shared vision (by patients, healthcare professionals, ARS, HAS, and the Ministry in the first place) of the meaning of the action taken by hospitals, and the development of a policy enabling hospitals to become both learning and highly reliable.
Main objective:
To evaluate the management process of the Covid-19 epidemic by the university hospitals of the Auvergne-Rhône-Alpes region, and the structures linked to them (establishments in their territory, ARS, user associations), in terms of points of improvement and good practices. This evaluation concerns the preparation, management and exit phases of the crisis.
연구 개요
상태
정황
연구 유형
등록 (예상)
연락처 및 위치
연구 연락처
- 이름: Julie HAESEBAERT, MD
- 전화번호: +33 4 72 68 49 05
- 이메일: julie.haesebaert01@chu-lyon.fr
연구 연락처 백업
- 이름: Philippe MICHEL, MD
- 전화번호: +33 4 72 40 71 03
- 이메일: philippe.michel@chu-lyon.fr
연구 장소
-
-
-
Clermont-Ferrand, 프랑스, 63003
- 모병
- CHU Clermont-Ferrand , Pôle de Santé Publique, unité d'Epidémiologie, Economie de la Santé et Prévention
-
연락하다:
- Laurent GERBAUD, MD
- 이메일: lgerbaud@chu-clermontferrand.fr
-
Grenoble, 프랑스, 38700
- 모병
- CHU Grenoble, Pôle Santé Publique, service de veille sanitaire
-
연락하다:
- Patrice FRANCOIS, MD
- 이메일: PFrancois@chu-grenoble.fr
-
Lyon, 프랑스, 69002
- 모병
- Hospices Civils de Lyon, DOQ-RU
-
연락하다:
- Philippe MICHEL, MD
- 전화번호: +33 4 72 40 71 03
- 이메일: philippe.michel@chu-lyon.fr
-
Saint-Étienne, 프랑스, 42055
- 모병
- CHU Saint-Etienne , Unité de gestion du risque infectieux
-
연락하다:
- Philippe BERTHELOT, MD
- 이메일: Philippe.berthelot@chu-st-Etienne.fr
-
-
참여기준
자격 기준
공부할 수 있는 나이
건강한 자원 봉사자를 받아들입니다
연구 대상 성별
샘플링 방법
연구 인구
- Professionals and members of the institutions' bodies in the 4 university hospitals: Lyon, St Etienne, Clermont Ferrand, Grenoble
- Adult patients hospitalized for at least 48 hours during the first wave of the pandemic COVID-19 in the 4 university hospitals: Lyon, St Etienne, Clermont Ferrand, Grenoble
설명
Inclusion Criteria:
Establishments :
- 4 university hospitals: Lyon, St Etienne, Clermont Ferrand, Grenoble
- Establishments in the same territories, public and private
Professionals and members of the institutions' bodies:
- Governance: management and chair of the CME
- Management (care, communication, medical, technical, logistics, IT, personnel)
- Clinical and public health cluster governance
- Medical, paramedical and non-medical staff in the departments most concerned (emergency and EMS reception, intensive care, infectiology, hygiene, virology, imaging, occupational medicine in particular)
- Organizations representing the personnel
- Members of the users' representatives committee
- Adult patients hospitalized for at least 48 hours during the study period (quantitative study by questionnaires).
Exclusion Criteria:
- none
공부 계획
연구는 어떻게 설계됩니까?
디자인 세부사항
코호트 및 개입
그룹/코호트 |
개입 / 치료 |
|---|---|
|
Professional qualitative group
Qualitative analysis of crisis management by interviewing professionals most involved during the crisis in each university hospital.
|
3 individual interviews with the different categories of professionals most involved during the crisis in each university hospital. In the first phase, the points of improvement identified will be analyzed In the second phase, good practices and innovations will be analyzed. For these first two phases, the duration of one hour was chosen because it is difficult to mobilize the professionals for longer. Individual interviews are preferred, but group interviews are possible with no more than three people so that everyone can express himself or herself. Finally, individual interviews of 15 to 30 minutes will be conducted with some of the people interviewed previously in order to identify the costs of the dysfunctions or problems encountered during the crisis. Questionnaires with establishments associated with the crisis management, the ARS AuRA and France Assos Santé AuRA. Analysis of evidence documents in the university hospitals |
|
Professional quantitative group
Quantitative analysis of crisis management using the WHO grid adapted sent to the target persons identified within the establishments
|
A self-assessment of the three phases of the crisis management process (preparation, crisis management, crisis recovery) will be carried out in the participating establishments using the WHO grid with the target persons identified within the establishments. This step will use the crisis response assessment tool developed by the WHO following the H1N1 pandemic in 2011. This grid will be adapted beforehand to the COVID-19 situation and to the local organization by the study's scientific committee. The dimensions investigated will be : Command and control, Communication, Safety and security, Triage, Surge capacity, Continuity of essential services; Human resources, Logistics and supply management, Post-disaster recovery. The grids will be sent to the 4 university hospitals to be filled in with the target audience recommended by the WHO methodological guide. The results of this self-assessment will be linked to and interpreted with the results of the interviews in phase 1. |
|
Patient quantitative group
Quantitative analysis of crisis management using a questionnaire sent to patients hospitalized in the first wave asking them about their perception of crisis and post-crisis management.
|
A questionnaire of patients' perceptions on the same perimeter (crisis and post-crisis management, from the point of view of points of improvement and good practices) will be constructed and sent by the management of the establishments to all patients hospitalized for 48 hours or more during the first wave and who have left their email address (methods similar to the e-satis survey). The online questionnaire survey is preferred in order to get away from the emotion and for feasibility reasons. This patient experience questionnaire adapted to COVID will be co-constructed with expert/partner patients and user associations. Four dimensions will be investigated : The perception of the quality of the information received by the patient, The nature of the information on the specific health protection protocol from which the patient benefited, The patient's consideration of the overall context, during and after, The effects of the health context on the overall management of the patient |
|
Tools development
Development of tools to prepare for situations of uncertainty
|
Development of tools to prepare for situations of uncertainty : In the third phase of the project, design thinking workshops will be organized (within the HCL) to develop training (in the form of simulation) in order to appropriate virtuous practices in situations of uncertainty. The purpose of these training sessions will be to improve the institution's ability to learn in a situation of uncertainty and thus to develop its reliability. The aim of these workshops is to provide tools for raising awareness of situations of uncertainty to all hospital staff. |
연구는 무엇을 측정합니까?
주요 결과 측정
결과 측정 |
측정값 설명 |
기간 |
|---|---|---|
|
Crisis management process based on a qualitative approach
기간: The Qualitative analysis (intervention 1) will take place from September, 2020 to December, 2021
|
The qualitative evaluation (interviews, document review) will make it possible to identify the points of improvement and virtuous practices implemented in the establishments.
|
The Qualitative analysis (intervention 1) will take place from September, 2020 to December, 2021
|
|
Crisis management process based on a quantitative approach with the professionals (identified within the establishments)
기간: The Quantitative analysis for professionals (intervention 2) will be conducted from March, 2021 to June 2021.
|
The quantitative evaluation will be based on the WHO checklist.
This first part will report, for each hospital, the proportion of items validated in each dimension of the WHO checklist (https://www.who.int/publications/i/item/hospital-emergency-response-checklist):
|
The Quantitative analysis for professionals (intervention 2) will be conducted from March, 2021 to June 2021.
|
|
Crisis management process based on a quantitative approach with the patients (hospitalized in the first wave)
기간: The Quantitative analysis for patients (intervention 3) will be conducted from March, 2021 to June 2021. The tool development phase (intervention 4) will be carried out from January, 2022 to June, 2022
|
The second quantitative evaluation will be based on patients' perceptions with a constructed questionnaire on theses perimeters: crisis and post-crisis management, from the point of view of points of improvement and good practices. This patient experience questionnaire will be adapted to COVID with expert/partner patients and user associations. |
The Quantitative analysis for patients (intervention 3) will be conducted from March, 2021 to June 2021. The tool development phase (intervention 4) will be carried out from January, 2022 to June, 2022
|
공동 작업자 및 조사자
연구 기록 날짜
연구 주요 날짜
연구 시작 (실제)
기본 완료 (예상)
연구 완료 (예상)
연구 등록 날짜
최초 제출
QC 기준을 충족하는 최초 제출
처음 게시됨 (실제)
연구 기록 업데이트
마지막 업데이트 게시됨 (실제)
QC 기준을 충족하는 마지막 업데이트 제출
마지막으로 확인됨
추가 정보
이 연구와 관련된 용어
추가 관련 MeSH 약관
기타 연구 ID 번호
- 69HCL20_0466
약물 및 장치 정보, 연구 문서
미국 FDA 규제 의약품 연구
미국 FDA 규제 기기 제품 연구
이 정보는 변경 없이 clinicaltrials.gov 웹사이트에서 직접 가져온 것입니다. 귀하의 연구 세부 정보를 변경, 제거 또는 업데이트하도록 요청하는 경우 register@clinicaltrials.gov. 문의하십시오. 변경 사항이 clinicaltrials.gov에 구현되는 즉시 저희 웹사이트에도 자동으로 업데이트됩니다. .
코로나19에 대한 임상 시험
-
Brugmann University Hospital모병
-
Istituti Clinici Scientifici Maugeri SpAIstituto Auxologico Italiano; Azienda Ospedaliera Bolognini di Seriate Bergamo; Azienda Socio... 그리고 다른 협력자들완전한
-
Abderrahmane Mami HospitalDacima Consulting; Eshmoun Clinical Research Center빼는
-
Centro de Educación Medica e Investigaciones Clínicas...완전한